Role of E-Health and Mobile Health in Management of Asthma: A Review Study

Background: Asthma is one of the common non-communicable diseases. Some 235 million people suffer from asthma around the world. Appropriate management of asthma can enable people to enjoy a good quality of life. The major international clinical guidelines now recommend including of self-management program in the routine management of patients of asthma. However, the implementation of self- management program in clinical practice, and their uptake by patients, is still poor. Objectives: We investigated the literature for finding last evidences about effect of e health and m health on different aspects of management of Asthma. Materials/Patients and Methods: Academic databases of PubMed, Cochrane (Central) and Scopus were searched, using different combinations of terms such as “ e health”, “ E Health”, mobile health, “m health” “M Health”, “M health”, ”Tele monitoring”, ”SMS”, ”MMS” ”Asthma”. The searching was limited to English language and Only systematic review or meta-analysis studies were reviewed. Results: We found 10 systematic review (SR) studies that included assessment of e health or m health on management of Asthma. These SR studies included RCT (Randomized Control Trials), before-after and observational studies. These studies consisted of at least a total 134556 participants comprising 10374 children. These studies conducted in USA, Cameron, Italy, France, Canada and some other countries. In these studies different aspects of Asthma evaluated such as self-management, medical adherence, scheduling visiting time by physicians, peak expiratory flow measurement, asynchronous communication and discussing between patients and providers, and monitoring four items of asthma (cough, night symptoms, sleep quality and maximum tolerated activity). However, few studies investigated the cost effectiveness and long term efficacy of m health or other e health facilities on management of asthmatic patients. Conclusion: Although there are some strong evidences regarding the value of integrating m health in management of asthma, but evidences about its long term benefit, cost-effectiveness, feasibility and changing the outcome are limited. Therefore, the lack of large scale and strong clinical trial studies to answer these questions is felt more than before.